respiratory

NEW DELHI: Our battle with toxic air across cities is showing up sharply in medical bills. Sales of respiratory medicines, including anti-allergics and anti-asthma therapies, surged past Rs 1,950 crore in Dec 2025, the highest monthly level ever, signalling a troubling escalation in pollution-linked illnesses. The Dec sales were 10% higher than the corresponding month…